Drugs that contain Sarecycline Hydrochloride

1. Drug name - SEYSARA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8318706 ALMIRALL Substituted tetracycline compounds
May, 2031

(8 years from now)

US9255068 ALMIRALL Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same
Feb, 2033

(10 years from now)

EP2450347B1 ALMIRALL Tetracycline Derivatives For The Treatment Of Bacterial, Viral And Parasitic Infections
Dec, 2027

(5 years from now)

EP2455367B1 ALMIRALL Tetracycline Derivatives For The Treatment Of Bacterial, Viral And Parasitic Infections
Dec, 2027

(5 years from now)

EP2109602A2 ALMIRALL Tetracycline Derivatives For The Treatment Of Bacterial, Viral And Parasitic Infections
Dec, 2027

(5 years from now)

EP2450347A1 ALMIRALL Tetracycline Derivatives For The Treatment Of Bacterial, Viral And Parasitic Infections
Dec, 2027

(5 years from now)

EP2455367A1 ALMIRALL Tetracycline Derivatives For The Treatment Of Bacterial, Viral And Parasitic Infections
Dec, 2027

(5 years from now)

EP2109602B1 ALMIRALL Tetracycline Derivatives For The Treatment Of Bacterial, Viral And Parasitic Infections
Dec, 2027

(5 years from now)

EP2707003A1 ALMIRALL Crystalline Salts Of (4S,4As,5Ar,12As)-4-Dimethylamino-3,10,12,12A-Tetrahydroxy-7-[(Methoxy(Methyl)Amino)-Methyl]-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydro-Naphthacene-2-Carboxylic Acid Amide And Methods Of Using The Same
May, 2032

(9 years from now)

EP2707003A4 ALMIRALL Crystalline Salts Of (4S,4As,5Ar,12As)-4-Dimethylamino-3,10,12,12A-Tetrahydroxy-7-[(Methoxy(Methyl)Amino)-Methyl]-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydro-Naphthacene-2-Carboxylic Acid Amide And Methods Of Using The Same
May, 2032

(9 years from now)

EP2707003B1 ALMIRALL Crystalline Salts Of (4S,4As,5Ar,12As)-4-Dimethylamino-3,10,12,12A-Tetrahydroxy-7-[(Methoxy(Methyl)Amino)-Methyl]-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydro-Naphthacene-2-Carboxylic Acid Amide And Methods Of Using The Same
May, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9481639 ALMIRALL Substituted tetracycline compounds for treatment of inflammatory skin disorders Aug, 2028

(5 years from now)

US8513223 ALMIRALL Substituted tetracycline compounds for treatment of inflammatory skin disorders Dec, 2029

(7 years from now)

Treatment: A method for treating acne in inflammatory lesions of non-nodular moderate to severe acne vulgaris patients 9 years of age and older comprising administering sarecycline hydrochloride in 60 mg, 100 mg or 150 mg equivalent doses; A method for treating a patient 9 years of age and older suffering from an inflammatory skin disorder of non-nodular moderate to severe acne vulgaris comprising administering an effective amount of sarecycline hydrochloride

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 60MG BASE TABLET;ORAL Prescription
EQ 100MG BASE TABLET;ORAL Prescription
EQ 150MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.